Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Related Research units
Abstract
The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 7 |
| ISSN | 1470-2045 |
| Publication status | Published - 2013 |
| pubmed | 23683750 |
|---|
